Abstract
Abstract Aryl hydrocarbon receptor (AhR), a ligand-induced transcription factor, is known to be involved in the balance between inflammatory and suppressive/regulatory T cell activity. Mesenchymal stem cells (MSCs) possess immunomodulatory activities, including suppression of T- and B-cell activation. MSC-mediated immunosuppression occurs via nitric oxide (NO) in mice. Here, we isolated MSCs from Ahr−/− bone marrow in mice and found less immunosuppressive function compared to the wild type (WT)-MSCs. When MSCs are co-cultured with T cells in the presence of anti-CD3 and anti-CD28 antibodies, the AhR-deficient MSCs less inhibited T-cell proliferation, CD25 and CD122 expression and cytokine productions such as IFN-γ, IL-17A compared with wild type MSCs. In addition, we found AhR-deficient MSCs produce less inducible nitric oxide synthase (iNOS) and NO compared with wild type MSCs, when MSCs were stimulated with IFN-γ, TNF-α, and IL-1β. Since MSCs has been used for the treatment of graft-vs-host disease (GvHD), we injected the WT and AhR-deficient MSCs into the GvHD mice. The AhR-deficient MSCs showed less therapeutic efficacy compared to the WT MSCs. We think that the AhR is involved in the production of NO via regulating iNOS expression which is required for the therapeutic efficacy of MSCs.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
